| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 1.461 | 4.985 | 5.069 | 4.384 | 6.376 | 6.873 | 16.726 |
| Total Income - EUR | - | - | 0 | 1.461 | 4.985 | 5.069 | 4.384 | 6.376 | 6.873 | 16.729 |
| Total Expenses - EUR | - | - | 0 | 533 | 1.978 | 2.246 | 2.975 | 4.909 | 10.602 | 11.159 |
| Gross Profit/Loss - EUR | - | - | 0 | 928 | 3.006 | 2.823 | 1.408 | 1.467 | -3.729 | 5.570 |
| Net Profit/Loss - EUR | - | - | 0 | 884 | 2.857 | 2.678 | 1.277 | 1.292 | -3.797 | 5.411 |
| Employees | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anathesis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 223 | 0 | 0 | 0 | 799 | 470 | 138 | 730 |
| Current Assets | - | - | 44 | 942 | 4.374 | 4.158 | 5.021 | 6.856 | 6.379 | 11.437 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 722 | 241 | 4.288 | 669 |
| Cash | - | - | 44 | 942 | 4.374 | 4.158 | 4.299 | 6.614 | 2.091 | 10.768 |
| Shareholders Funds | - | - | 44 | 927 | 3.766 | 3.544 | 4.743 | 6.049 | 2.233 | 8.407 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 223 | 60 | 607 | 619 | 1.077 | 1.400 | 3.787 | 3.204 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 586 | 582 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Anathesis S.r.l.